APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cannabidiol (CBD)

Cannabidiol (CBD) is a natural botanical concentrate that is high in the compound CBD. Of the more than 85 cannabinoids so far identified in the cannabis plant, CBD is the second most common after tetrahydrocannabinol (THC).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cannabidiol (CBD) is a natural botanical concentrate that is high in the compound CBD. Of the more than 85 cannabinoids so far identified in the cannabis plant, CBD is the second most common after tetrahydrocannabinol (THC).

And in our report, the Cannabidiol (CBD) product refers in particular to Cannabidiol (CBD) Oil.

Selected research

Market Outlook & Growth Opportunities

Global Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026

Report ID 173974580421 December 2025202 pages

Choose your research edition.

Industry ResearchCannabidiol (CBD) Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Cannabidiol (CBD) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Cannabidiol (CBD) is a natural botanical concentrate that is high in the compound CBD. Of the more than 85 cannabinoids so far identified in the cannabis plant, CBD is the second most common after tetrahydrocannabinol (THC).

And in our report, the Cannabidiol (CBD) product refers in particular to Cannabidiol (CBD) Oil.

Cannabidiol (CBD) oil is a natural botanical concentrate that is high in the compound CBD. Of the more than 85 cannabinoids so far identified in the cannabis plant, CBD is the second most common after tetrahydrocannabinol (THC).

Read the full market overview

In the last few years, global market of Cannabidiol Oil (CBD Oil) developed rapidly, stimulated by the increasing demand from North America and Europe.

Presently, the production of Cannabidiol Oil (CBD Oil) is mainly concentrated in Europe and North America. Many producers of Cannabidiol Oil (CBD Oil) in the industry have formed an integrated industry chain, from the industrial hemp to downstream industries. Most of them can provide various finished products of Cannabidiol Oil (CBD Oil) to customers directly.

Online sales are the most common marketing channel for CBD based products in Europe and North America.

This report provides an overview of the global Cannabidiol (CBD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cannabidiol (CBD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cannabidiol (CBD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cannabidiol (CBD) market size, projected growth trends, production technologies, key applications, and end-use industries.

Cannabidiol (CBD) Segment by Company

Kazmira

CW Hemp/CW Botanicals

Freedom Leaf

Green Road

Medical Marijuana

Folium Biosciences

HempLife Today

Cannavest

Pharmahemp

ENDOCA

CBD American Shaman

NuLeaf Naturals

Select Oil

K.I.N.D. Concentrates

Canopy Growth Corporation

Aphria

Emblem Cannabis Oils

Whistler

The Lab

Absolute Terps

Cannabidiol (CBD) Segment by Type

Hemp-derived Type

Marijuana-derived Type

Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Cannabidiol (CBD) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Cannabidiol (CBD) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cannabidiol (CBD) significant trends, drivers, influence factors in global and regions.

6. To analyze Cannabidiol (CBD) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cannabidiol (CBD) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cannabidiol (CBD) industry.

Chapter 3: Detailed analysis of Cannabidiol (CBD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Cannabidiol (CBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Cannabidiol (CBD) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cannabidiol (CBD) Industry Trends Table 2. Cannabidiol (CBD) Industry Drivers Table 3. Cannabidiol (CBD) Industry Opportunities and Challenges Table 4. Cannabidiol (CBD) Industry Restraints Table 5. Global Cannabidiol (CBD) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cannabidiol (CBD) Revenue Share by Company (2021-2026) Table 7. Global Cannabidiol (CBD) Sales Volume by Company (KG) & (2021-2026) Table 8. Global Cannabidiol (CBD) Sales Volume Share by Company (2021-2026) Table 9. Global Cannabidiol (CBD) Average Price (USD/g) of Company (2021-2026) Table 10. Global Cannabidiol (CBD) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Cannabidiol (CBD) Key Company Manufacturing Base & Headquarters Table 12. Global Cannabidiol (CBD) Company, Product Type & Application Table 13. Global Cannabidiol (CBD) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Cannabidiol (CBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Hemp-derived Type Table 18. Significant Companies of Marijuana-derived Type Table 19. Global Cannabidiol (CBD) Sales Volume by Type 2021 VS 2025 VS 2032 (KG) Table 20. Global Cannabidiol (CBD) Sales Volume by Type (2021-2026) & (KG) Table 21. Global Cannabidiol (CBD) Sales Volume by Type (2027-2032) & (KG) Table 22. Global Cannabidiol (CBD) Sales Volume Share by Type (2021-2026) Table 23. Global Cannabidiol (CBD) Sales Volume Share by Type (2027-2032) Table 24. Global Cannabidiol (CBD) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cannabidiol (CBD) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Cannabidiol (CBD) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Cannabidiol (CBD) Sales Value Share by Type (2021-2026) Table 28. Global Cannabidiol (CBD) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Pharmaceuticals Industry Table 30. Significant Companies of Food Industry Table 31. Significant Companies of Cosmetics Industry Table 32. Significant Companies of Other Table 33. Global Cannabidiol (CBD) Sales Volume by Application 2021 VS 2025 VS 2032 (KG) Table 34. Global Cannabidiol (CBD) Sales Volume by Application (2021-2026) & (KG) Table 35. Global Cannabidiol (CBD) Sales Volume by Application (2027-2032) & (KG) Table 36. Global Cannabidiol (CBD) Sales Volume Share by Application (2021-2026) Table 37. Global Cannabidiol (CBD) Sales Volume Share by Application (2027-2032) Table 38. Global Cannabidiol (CBD) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cannabidiol (CBD) Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Cannabidiol (CBD) Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Cannabidiol (CBD) Sales Value Share by Application (2021-2026) Table 42. Global Cannabidiol (CBD) Sales Value Share by Application (2027-2032) Table 43. Global Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (KG) Table 44. Global Cannabidiol (CBD) Sales by Region (2021-2026) & (KG) Table 45. Global Cannabidiol (CBD) Sales Market Share by Region (2021-2026) Table 46. Global Cannabidiol (CBD) Sales by Region (2027-2032) & (KG) Table 47. Global Cannabidiol (CBD) Sales Market Share by Region (2027-2032) Table 48. Global Cannabidiol (CBD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Cannabidiol (CBD) Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Cannabidiol (CBD) Sales Value Share by Region (2021-2026) Table 51. Global Cannabidiol (CBD) Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Cannabidiol (CBD) Sales Value Share by Region (2027-2032) Table 53. Global Cannabidiol (CBD) Market Average Price (USD/g) by Region (2021-2026) Table 54. Global Cannabidiol (CBD) Market Average Price (USD/g) by Region (2027-2032) Table 55. Global Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (KG) Table 56. Global Cannabidiol (CBD) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Cannabidiol (CBD) Sales by Country (2021-2026) & (KG) Table 58. Global Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 59. Global Cannabidiol (CBD) Sales by Country (2027-2032) & (KG) Table 60. Global Cannabidiol (CBD) Sales Market Share by Country (2027-2032) Table 61. Global Cannabidiol (CBD) Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Cannabidiol (CBD) Sales Value Market Share by Country (2021-2026) Table 63. Global Cannabidiol (CBD) Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Cannabidiol (CBD) Sales Value Market Share by Country (2027-2032) Table 65. Kazmira Company Information Table 66. Kazmira Business Overview Table 67. Kazmira Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 68. Kazmira Cannabidiol (CBD) Product Portfolio Table 69. Kazmira Recent Development Table 70. CW Hemp/CW Botanicals Company Information Table 71. CW Hemp/CW Botanicals Business Overview Table 72. CW Hemp/CW Botanicals Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 73. CW Hemp/CW Botanicals Cannabidiol (CBD) Product Portfolio Table 74. CW Hemp/CW Botanicals Recent Development Table 75. Freedom Leaf Company Information Table 76. Freedom Leaf Business Overview Table 77. Freedom Leaf Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 78. Freedom Leaf Cannabidiol (CBD) Product Portfolio Table 79. Freedom Leaf Recent Development Table 80. Green Road Company Information Table 81. Green Road Business Overview Table 82. Green Road Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 83. Green Road Cannabidiol (CBD) Product Portfolio Table 84. Green Road Recent Development Table 85. Medical Marijuana Company Information Table 86. Medical Marijuana Business Overview Table 87. Medical Marijuana Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 88. Medical Marijuana Cannabidiol (CBD) Product Portfolio Table 89. Medical Marijuana Recent Development Table 90. Folium Biosciences Company Information Table 91. Folium Biosciences Business Overview Table 92. Folium Biosciences Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 93. Folium Biosciences Cannabidiol (CBD) Product Portfolio Table 94. Folium Biosciences Recent Development Table 95. HempLife Today Company Information Table 96. HempLife Today Business Overview Table 97. HempLife Today Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 98. HempLife Today Cannabidiol (CBD) Product Portfolio Table 99. HempLife Today Recent Development Table 100. Cannavest Company Information Table 101. Cannavest Business Overview Table 102. Cannavest Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 103. Cannavest Cannabidiol (CBD) Product Portfolio Table 104. Cannavest Recent Development Table 105. Pharmahemp Company Information Table 106. Pharmahemp Business Overview Table 107. Pharmahemp Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 108. Pharmahemp Cannabidiol (CBD) Product Portfolio Table 109. Pharmahemp Recent Development Table 110. ENDOCA Company Information Table 111. ENDOCA Business Overview Table 112. ENDOCA Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 113. ENDOCA Cannabidiol (CBD) Product Portfolio Table 114. ENDOCA Recent Development Table 115. CBD American Shaman Company Information Table 116. CBD American Shaman Business Overview Table 117. CBD American Shaman Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 118. CBD American Shaman Cannabidiol (CBD) Product Portfolio Table 119. CBD American Shaman Recent Development Table 120. NuLeaf Naturals Company Information Table 121. NuLeaf Naturals Business Overview Table 122. NuLeaf Naturals Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 123. NuLeaf Naturals Cannabidiol (CBD) Product Portfolio Table 124. NuLeaf Naturals Recent Development Table 125. Select Oil Company Information Table 126. Select Oil Business Overview Table 127. Select Oil Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 128. Select Oil Cannabidiol (CBD) Product Portfolio Table 129. Select Oil Recent Development Table 130. K.I.N.D. Concentrates Company Information Table 131. K.I.N.D. Concentrates Business Overview Table 132. K.I.N.D. Concentrates Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 133. K.I.N.D. Concentrates Cannabidiol (CBD) Product Portfolio Table 134. K.I.N.D. Concentrates Recent Development Table 135. Canopy Growth Corporation Company Information Table 136. Canopy Growth Corporation Business Overview Table 137. Canopy Growth Corporation Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 138. Canopy Growth Corporation Cannabidiol (CBD) Product Portfolio Table 139. Canopy Growth Corporation Recent Development Table 140. Aphria Company Information Table 141. Aphria Business Overview Table 142. Aphria Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 143. Aphria Cannabidiol (CBD) Product Portfolio Table 144. Aphria Recent Development Table 145. Emblem Cannabis Oils Company Information Table 146. Emblem Cannabis Oils Business Overview Table 147. Emblem Cannabis Oils Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 148. Emblem Cannabis Oils Cannabidiol (CBD) Product Portfolio Table 149. Emblem Cannabis Oils Recent Development Table 150. Whistler Company Information Table 151. Whistler Business Overview Table 152. Whistler Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 153. Whistler Cannabidiol (CBD) Product Portfolio Table 154. Whistler Recent Development Table 155. The Lab Company Information Table 156. The Lab Business Overview Table 157. The Lab Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 158. The Lab Cannabidiol (CBD) Product Portfolio Table 159. The Lab Recent Development Table 160. Absolute Terps Company Information Table 161. Absolute Terps Business Overview Table 162. Absolute Terps Cannabidiol (CBD) Sales (KG), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 163. Absolute Terps Cannabidiol (CBD) Product Portfolio Table 164. Absolute Terps Recent Development Table 165. Key Raw Materials Table 166. Raw Materials Key Suppliers Table 167. Cannabidiol (CBD) Distributors List Table 168. Cannabidiol (CBD) Customers List Table 169. Research Programs/Design for This Report Table 170. Authors List of This Report Table 171. Secondary Sources Table 172. Primary Sources List of Figures Figure 1. Cannabidiol (CBD) Product Image Figure 2. Global Cannabidiol (CBD) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Cannabidiol (CBD) Sales (2021-2032) & (KG) Figure 5. Global Cannabidiol (CBD) Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Cannabidiol (CBD) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Hemp-derived Type Image Figure 10. Marijuana-derived Type Image Figure 11. Global Cannabidiol (CBD) Sales Volume by Type (2021 VS 2025 VS 2032) & (KG) Figure 12. Global Cannabidiol (CBD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Cannabidiol (CBD) Sales Volume Share by Type (2021-2032) Figure 14. Global Cannabidiol (CBD) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Cannabidiol (CBD) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Cannabidiol (CBD) Sales Value Share by Type (2021-2032) Figure 17. Pharmaceuticals Industry Image Figure 18. Food Industry Image Figure 19. Cosmetics Industry Image Figure 20. Other Image Figure 21. Global Cannabidiol (CBD) Sales Volume by Application (2021 VS 2025 VS 2032) & (KG) Figure 22. Global Cannabidiol (CBD) Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Cannabidiol (CBD) Sales Volume Share by Application (2021-2032) Figure 24. Global Cannabidiol (CBD) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Cannabidiol (CBD) Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Cannabidiol (CBD) Sales Value Share by Application (2021-2032) Figure 27. Global Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (KG) Figure 28. Global Cannabidiol (CBD) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Cannabidiol (CBD) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Cannabidiol (CBD) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 32. North America Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 38. South America Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Cannabidiol (CBD) Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Cannabidiol (CBD) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Cannabidiol (CBD) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Cannabidiol (CBD) Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Cannabidiol (CBD) Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Hemp-derived Type
  • Marijuana-derived Type
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Kazmira
  • CW Hemp/CW Botanicals
  • Freedom Leaf
  • Green Road
  • Medical Marijuana
  • Folium Biosciences
  • HempLife Today
  • Cannavest
  • Pharmahemp
  • ENDOCA
  • CBD American Shaman
  • NuLeaf Naturals
  • Select Oil
  • K.I.N.D. Concentrates
  • Canopy Growth Corporation
  • Aphria
  • Emblem Cannabis Oils
  • Whistler
  • The Lab
  • Absolute Terps

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cannabidiol (CBD) Sales Value (2021-2032)
  4. 1.2.2 Global Cannabidiol (CBD) Sales Volume (2021-2032)
  5. 1.2.3 Global Cannabidiol (CBD) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Cannabidiol (CBD) Market Dynamics
  1. 2.1 Cannabidiol (CBD) Industry Trends
  2. 2.2 Cannabidiol (CBD) Industry Drivers
  3. 2.3 Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 2.4 Cannabidiol (CBD) Industry Restraints
3 Cannabidiol (CBD) Market by Company
  1. 3.1 Global Cannabidiol (CBD) Company Revenue Ranking in 2025
  2. 3.2 Global Cannabidiol (CBD) Revenue by Company (2021-2026)
  3. 3.3 Global Cannabidiol (CBD) Sales Volume by Company (2021-2026)
  4. 3.4 Global Cannabidiol (CBD) Average Price by Company (2021-2026)
  5. 3.5 Global Cannabidiol (CBD) Company Ranking (2024-2026)
  6. 3.6 Global Cannabidiol (CBD) Company Manufacturing Base and Headquarters
  7. 3.7 Global Cannabidiol (CBD) Company Product Type and Application
  8. 3.8 Global Cannabidiol (CBD) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Cannabidiol (CBD) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Cannabidiol (CBD) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Cannabidiol (CBD) Market by Type
  1. 4.1 Cannabidiol (CBD) Type Introduction
  2. 4.1.1 Hemp-derived Type
  3. 4.1.2 Marijuana-derived Type
  4. 4.2 Global Cannabidiol (CBD) Sales Volume by Type
  5. 4.2.1 Global Cannabidiol (CBD) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cannabidiol (CBD) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Cannabidiol (CBD) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Cannabidiol (CBD) Sales Value by Type
  9. 4.3.1 Global Cannabidiol (CBD) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cannabidiol (CBD) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Cannabidiol (CBD) Sales Value Share by Type (2021-2032)
5 Cannabidiol (CBD) Market by Application
  1. 5.1 Cannabidiol (CBD) Application Introduction
  2. 5.1.1 Pharmaceuticals Industry
  3. 5.1.2 Food Industry
  4. 5.1.3 Cosmetics Industry
  5. 5.1.4 Other
  6. 5.2 Global Cannabidiol (CBD) Sales Volume by Application
  7. 5.2.1 Global Cannabidiol (CBD) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cannabidiol (CBD) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Cannabidiol (CBD) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Cannabidiol (CBD) Sales Value by Application
  11. 5.3.1 Global Cannabidiol (CBD) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cannabidiol (CBD) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Cannabidiol (CBD) Sales Value Share by Application (2021-2032)
6 Cannabidiol (CBD) Regional Sales and Value Analysis
  1. 6.1 Global Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cannabidiol (CBD) Sales by Region (2021-2032)
  3. 6.2.1 Global Cannabidiol (CBD) Sales by Region: 2021-2026
  4. 6.2.2 Global Cannabidiol (CBD) Sales by Region (2027-2032)
  5. 6.3 Global Cannabidiol (CBD) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Cannabidiol (CBD) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Cannabidiol (CBD) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Cannabidiol (CBD) Sales Value by Region (2027-2032)
  9. 6.5 Global Cannabidiol (CBD) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Cannabidiol (CBD) Sales Value (2021-2032)
  12. 6.6.2 North America Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Cannabidiol (CBD) Sales Value (2021-2032)
  15. 6.7.2 Europe Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Cannabidiol (CBD) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Cannabidiol (CBD) Sales Value (2021-2032)
  21. 6.9.2 South America Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Cannabidiol (CBD) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Cannabidiol (CBD) Sales Value Share by Country, 2025 VS 2032
7 Cannabidiol (CBD) Country-level Sales and Value Analysis
  1. 7.1 Global Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cannabidiol (CBD) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Cannabidiol (CBD) Sales by Country (2021-2032)
  4. 7.3.1 Global Cannabidiol (CBD) Sales by Country (2021-2026)
  5. 7.3.2 Global Cannabidiol (CBD) Sales by Country (2027-2032)
  6. 7.4 Global Cannabidiol (CBD) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Cannabidiol (CBD) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Cannabidiol (CBD) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Cannabidiol (CBD) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Cannabidiol (CBD) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Cannabidiol (CBD) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kazmira
  2. 8.1.1 Kazmira Company Information
  3. 8.1.2 Kazmira Business Overview
  4. 8.1.3 Kazmira Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kazmira Cannabidiol (CBD) Product Portfolio
  6. 8.1.5 Kazmira Recent Developments
  7. 8.2 CW Hemp/CW Botanicals
  8. 8.2.1 CW Hemp/CW Botanicals Company Information
  9. 8.2.2 CW Hemp/CW Botanicals Business Overview
  10. 8.2.3 CW Hemp/CW Botanicals Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CW Hemp/CW Botanicals Cannabidiol (CBD) Product Portfolio
  12. 8.2.5 CW Hemp/CW Botanicals Recent Developments
  13. 8.3 Freedom Leaf
  14. 8.3.1 Freedom Leaf Company Information
  15. 8.3.2 Freedom Leaf Business Overview
  16. 8.3.3 Freedom Leaf Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Freedom Leaf Cannabidiol (CBD) Product Portfolio
  18. 8.3.5 Freedom Leaf Recent Developments
  19. 8.4 Green Road
  20. 8.4.1 Green Road Company Information
  21. 8.4.2 Green Road Business Overview
  22. 8.4.3 Green Road Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Green Road Cannabidiol (CBD) Product Portfolio
  24. 8.4.5 Green Road Recent Developments
  25. 8.5 Medical Marijuana
  26. 8.5.1 Medical Marijuana Company Information
  27. 8.5.2 Medical Marijuana Business Overview
  28. 8.5.3 Medical Marijuana Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medical Marijuana Cannabidiol (CBD) Product Portfolio
  30. 8.5.5 Medical Marijuana Recent Developments
  31. 8.6 Folium Biosciences
  32. 8.6.1 Folium Biosciences Company Information
  33. 8.6.2 Folium Biosciences Business Overview
  34. 8.6.3 Folium Biosciences Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Folium Biosciences Cannabidiol (CBD) Product Portfolio
  36. 8.6.5 Folium Biosciences Recent Developments
  37. 8.7 HempLife Today
  38. 8.7.1 HempLife Today Company Information
  39. 8.7.2 HempLife Today Business Overview
  40. 8.7.3 HempLife Today Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HempLife Today Cannabidiol (CBD) Product Portfolio
  42. 8.7.5 HempLife Today Recent Developments
  43. 8.8 Cannavest
  44. 8.8.1 Cannavest Company Information
  45. 8.8.2 Cannavest Business Overview
  46. 8.8.3 Cannavest Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cannavest Cannabidiol (CBD) Product Portfolio
  48. 8.8.5 Cannavest Recent Developments
  49. 8.9 Pharmahemp
  50. 8.9.1 Pharmahemp Company Information
  51. 8.9.2 Pharmahemp Business Overview
  52. 8.9.3 Pharmahemp Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Pharmahemp Cannabidiol (CBD) Product Portfolio
  54. 8.9.5 Pharmahemp Recent Developments
  55. 8.10 ENDOCA
  56. 8.10.1 ENDOCA Company Information
  57. 8.10.2 ENDOCA Business Overview
  58. 8.10.3 ENDOCA Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 ENDOCA Cannabidiol (CBD) Product Portfolio
  60. 8.10.5 ENDOCA Recent Developments
  61. 8.11 CBD American Shaman
  62. 8.11.1 CBD American Shaman Company Information
  63. 8.11.2 CBD American Shaman Business Overview
  64. 8.11.3 CBD American Shaman Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CBD American Shaman Cannabidiol (CBD) Product Portfolio
  66. 8.11.5 CBD American Shaman Recent Developments
  67. 8.12 NuLeaf Naturals
  68. 8.12.1 NuLeaf Naturals Company Information
  69. 8.12.2 NuLeaf Naturals Business Overview
  70. 8.12.3 NuLeaf Naturals Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 NuLeaf Naturals Cannabidiol (CBD) Product Portfolio
  72. 8.12.5 NuLeaf Naturals Recent Developments
  73. 8.13 Select Oil
  74. 8.13.1 Select Oil Company Information
  75. 8.13.2 Select Oil Business Overview
  76. 8.13.3 Select Oil Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Select Oil Cannabidiol (CBD) Product Portfolio
  78. 8.13.5 Select Oil Recent Developments
  79. 8.14 K.I.N.D. Concentrates
  80. 8.14.1 K.I.N.D. Concentrates Company Information
  81. 8.14.2 K.I.N.D. Concentrates Business Overview
  82. 8.14.3 K.I.N.D. Concentrates Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 K.I.N.D. Concentrates Cannabidiol (CBD) Product Portfolio
  84. 8.14.5 K.I.N.D. Concentrates Recent Developments
  85. 8.15 Canopy Growth Corporation
  86. 8.15.1 Canopy Growth Corporation Company Information
  87. 8.15.2 Canopy Growth Corporation Business Overview
  88. 8.15.3 Canopy Growth Corporation Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Canopy Growth Corporation Cannabidiol (CBD) Product Portfolio
  90. 8.15.5 Canopy Growth Corporation Recent Developments
  91. 8.16 Aphria
  92. 8.16.1 Aphria Company Information
  93. 8.16.2 Aphria Business Overview
  94. 8.16.3 Aphria Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Aphria Cannabidiol (CBD) Product Portfolio
  96. 8.16.5 Aphria Recent Developments
  97. 8.17 Emblem Cannabis Oils
  98. 8.17.1 Emblem Cannabis Oils Company Information
  99. 8.17.2 Emblem Cannabis Oils Business Overview
  100. 8.17.3 Emblem Cannabis Oils Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Emblem Cannabis Oils Cannabidiol (CBD) Product Portfolio
  102. 8.17.5 Emblem Cannabis Oils Recent Developments
  103. 8.18 Whistler
  104. 8.18.1 Whistler Company Information
  105. 8.18.2 Whistler Business Overview
  106. 8.18.3 Whistler Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Whistler Cannabidiol (CBD) Product Portfolio
  108. 8.18.5 Whistler Recent Developments
  109. 8.19 The Lab
  110. 8.19.1 The Lab Company Information
  111. 8.19.2 The Lab Business Overview
  112. 8.19.3 The Lab Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 The Lab Cannabidiol (CBD) Product Portfolio
  114. 8.19.5 The Lab Recent Developments
  115. 8.20 Absolute Terps
  116. 8.20.1 Absolute Terps Company Information
  117. 8.20.2 Absolute Terps Business Overview
  118. 8.20.3 Absolute Terps Cannabidiol (CBD) Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Absolute Terps Cannabidiol (CBD) Product Portfolio
  120. 8.20.5 Absolute Terps Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cannabidiol (CBD) Value Chain Analysis
  2. 9.1.1 Cannabidiol (CBD) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cannabidiol (CBD) Sales Mode & Process
  6. 9.2 Cannabidiol (CBD) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cannabidiol (CBD) Distributors
  9. 9.2.3 Cannabidiol (CBD) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst